HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages
- 1 November 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 18 (11), 1671-1678
- https://doi.org/10.1161/01.atv.18.11.1671
Abstract
—Macrophages secrete matrix metalloproteinases (MMPs) that may weaken the fibrous cap of atherosclerotic plaque, predisposing its fissuration. The 92-kDa gelatinase B (MMP-9) has been ident...Keywords
This publication has 28 references indexed in Scilit:
- The extracellular matrix and atherosclerosisCurrent Opinion in Lipidology, 1995
- Can Atherosclerotic Coronary Arteries Vasodilate? An Intraoperative High-Frequency Epicardial Echocardiographic StudyThe American Journal of Cardiology, 1995
- Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque ruptureJournal of the American College of Cardiology, 1994
- Requirement for mevalonate in acetylated LDL induction of cholesterol esterification in macrophagesAtherosclerosis, 1993
- Induction of collagenase and stromelysin gene expression by mechanical injury in a vascular smooth muscle‐derived cell lineJournal of Cellular Physiology, 1993
- Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitroJournal of Cellular Physiology, 1993
- Inhibition of Matrix Metalloproteinase 9 Activation by a Specific Monoclonal AntibodyHybridoma, 1993
- Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductaseAtherosclerosis, 1993
- Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content.Heart, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993